These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7459232)

  • 21. Cytogenetic analysis of an immunogenic mutant of the L5178Y lymphoma.
    Greenberg AH; Manougian J; Ray M; Goldenberg GJ
    Acta Cytol; 1980; 24(3):232-6. PubMed ID: 6773281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined effects of radiosensitizers and radioprotectors on cultured mammalian cells to Co-60 gamma-rays.
    Antoku S; Hoshi M
    J Radiat Res; 1984 Dec; 25(4):305-13. PubMed ID: 6442734
    [No Abstract]   [Full Text] [Related]  

  • 23. ADP-ribosylation and post-irradiation cellular recovery in two strains of L5178Y cells.
    Szumiel I; Włodek D; Johnson KJ; Sundell-Bergman S
    Br J Cancer Suppl; 1984; 6():33-8. PubMed ID: 6320854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part II: Biological evaluation-in vitro studies on the P 388 D1 leukemia cell line.
    Reile H; Müller R; Gust R; Laske R; Krischke W; Bernhardt G; Spruss T; Jennerwein M; Engel J; Seeber S
    Arch Pharm (Weinheim); 1990 Mar; 323(3):133-40. PubMed ID: 2344259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment of L5178Y-R and L5178Y-S cells with an antitumor platinum complex (cis-PAD) and ultraviolet light.
    Szumiel I
    Int J Radiat Oncol Biol Phys; 1980 Feb; 6(2):199-203. PubMed ID: 7190138
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
    Suzuki Y; Liu CM; Chen LP; Ben-Nathan D; Wheelock EF
    J Immunol; 1987 Nov; 139(9):3146-52. PubMed ID: 3117888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: in vivo and in vitro effects.
    Liu CM; Suzuki Y; Chen LP; Okayasu T; Calkins CE; Wheelock EF
    Cancer Res; 1990 Mar; 50(5):1361-7. PubMed ID: 2302701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clavines as antitumor agents. Part 5. In vitro activity of semisynthetic festuclavines.
    Eich E; Becker C; Eichberg D; Maidhof A; Müller WE
    Pharmazie; 1986 Feb; 41(2):156-7. PubMed ID: 3725861
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour cell-antibody interactions. I. In vivo experiments.
    Froese G; Berczi I; Israels LG
    Immunology; 1982 Feb; 45(2):303-12. PubMed ID: 7061100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recovery from potentially lethal damage of irradiated L5178Y-R and L5178Y-S cells: the effect of temperature and benzamide].
    Afanas'ev GG; Burachevska I; Godlevska E; Ludvitska A; Shumel' I
    Radiobiologiia; 1989; 29(6):776-81. PubMed ID: 2616754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice.
    Wheelock EF; Robinson MK; Truitt GA
    Cancer Metastasis Rev; 1982; 1(1):29-44. PubMed ID: 6985247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of L5178Y lymphoma growth by means of placental antigen immunization.
    Bravo-Cuéllar A; Gomez-Estrada H; Ramos-Damián M
    Arch Invest Med (Mex); 1982; 13(3):191-4 passim. PubMed ID: 7125799
    [No Abstract]   [Full Text] [Related]  

  • 34. Murine lymphoma L5178Y cells resistant to purine antagonists: differences in cross-resistance to thioguanine-platinum(II) and selenoguanine-platinum(II).
    Kanzawa F; Maeda M; Sasaki T; Hoshi A; Kuretani K
    J Natl Cancer Inst; 1982 Feb; 68(2):287-91. PubMed ID: 6950160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
    Trainer DL; Wheelock EF
    Cancer Res; 1984 Mar; 44(3):1063-71. PubMed ID: 6607108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejection of Fas ligand-expressing grafts.
    Seino K; Kayagaki N; Fukao K; Okumura K; Yagita H
    Transplant Proc; 1997; 29(1-2):1092-3. PubMed ID: 9123215
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.
    Trainer DL; Wheelock EF
    Cancer Res; 1984 Jul; 44(7):2897-906. PubMed ID: 6609767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation and thermal characteristics of mouse lymphoma cells and their radiation-sensitive mutant.
    Baba Y; Yasunaga T; Uozumi H; Takahashi M; Sawada S
    Radiat Med; 1988; 6(5):232-9. PubMed ID: 3231725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Location of tumoral antigens in L5178Y murine lymphoma cells.
    Ramos-Damián ME; Gómez-Estrada H; Hernández-Delgado J; Tapia-Arizmendi L; Feria-Velasco A
    Arch Invest Med (Mex); 1980; 11(3):425-34. PubMed ID: 7469659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of Ficoll gradient centrifugation to obtain synchronously growing L5178Y cells.
    Krynicka I; Krupska U; Malec J; Sitarska E
    Neoplasma; 1980; 27(2):193-6. PubMed ID: 7190228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.